Delivery Order SPE2DB22D1041-SPE2DB25FUAT8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets in a quantity of 90 units, with a ceiling value of $1,697.07. This competitively awarded, firm fixed-price contract is classified as non-set-aside and was completed on August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the delivery order from its location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets in a 90-count quantity, with a ceiling value of $8,641.99. This firm fixed-price delivery order, which is not set-aside designated, represents a continuation of AmerisourceBergen's pharmaceutical supply support under its larger contract vehicle with the DLA. Performance will be executed from the contractor's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a $20,047.15 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Valsartan-HCTZ 320-25 mg, a combination antihypertensive medication used to treat high blood pressure. This competitively awarded, firm fixed-price delivery order was issued on May 12, 2025, with an ultimate completion date of May 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine...
- The Defense Logistics Agency awarded a $1,224.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTZ 160-12.5 mg tablets (90-count supply) on July 22, 2025, with completion scheduled for July 23, 2025. The contract represents a non-competitive, non-set-aside delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $7,300.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTZ 160-12.5 mg tablets (90-count) on June 2, 2025, with completion scheduled for June 3, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) valued at $5,573.64. This is a firm fixed-price delivery order with no set-aside designation, and the product is scheduled for delivery by July 29, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $23,124.56 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count units) under a firm fixed-price contract. This non-set-aside delivery order, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-25 mg tablets (90-count supply) valued at $1,549.78 under a firm fixed price contract. The award was made on June 24, 2025, with an ultimate completion date of June 25, 2025, and is classified as a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this delivery order, which represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Valsartan-HCTZ 320-12.5 mg tablets (90-count) with a ceiling value of $6,931.74 under firm fixed-price terms. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 29, 2025, and performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTZ 160-12.5 mg tablets (90-count units) valued at $1,392.46 with a firm fixed price structure. This contract was competitively awarded without a set-aside designation and is scheduled for completion by September 30, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, supporting federal medical procurement needs for military and veteran healthcare...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUAT8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,068.09 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count supply). This competitive, non-set-aside delivery order represents a firm fixed price contract with a completion date of June 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Valsartan-HCTZ is a combination antihypertensive medication used to manage high blood pressure, and this procurement supports federal medical supply requirements for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The vendor's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through open competition, serving critical customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.1k | 6/2/25 |